Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimiter S Dimitrov

Showing results (181-190 of 284) with videos related to

Pageof 29
Sort By:
Journal of Virology|June 7, 2002
Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediatesHana Golding, Marina Zaitseva, Eve de Rosny, et al.
Plos One|May 27, 2015
Identification of Non-HIV Immunogens That Bind to Germline b12 Predecessors and Prime for Elicitation of Cross-clade Neutralizing HIV-1 AntibodiesZheng Yang, Jingjing Li, Qingsheng Liu, et al.
Cell Reports|December 16, 2021
Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody bindingDhiraj Mannar, James W Saville, Xing Zhu, et al.
IJU Case Reports|August 4, 2020
Bladder urothelial carcinoma producing insulin-like growth factor II: A case reportSatoshi Funada, Yuki Kita, Yoshiyuki Okada, et al.
Scientific Reports|August 20, 2016
Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus InfectionAnurodh Shankar Agrawal, Tianlei Ying, Xinrong Tao, et al.
Translational Oncology|November 12, 2021
Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cellsNayanendu Saha, Kai Xu, Zhongyu Zhu, et al.
Mabs|April 14, 2018
N-terminal α-amino group modification of antibodies using a site-selective click chemistry methodDe-Zhi Li, Bing-Nan Han, Rui Wei, et al.
International Journal of Biological Sciences|June 19, 2018
A dual-specific IGF-I/II human engineered antibody domain inhibits IGF signaling in breast cancer cellsZhizhen Chen, Jie Liu, Dafeng Chu, et al.
Briefings in Bioinformatics|September 16, 2024
AI-based IsAb2.0 for antibody designTianjian Liang, Ze-Yu Sun, Margaret G Hines, et al.
Small Methods|February 17, 2022
Design of a Novel Fab-Like Antibody Fragment with Enhanced Stability and Affinity for Clinical useChunyu Wang, Jiaxu Hong, Zhenlin Yang, et al.
Pageof 29

Showing results (181-190 of 284) with videos related to

Sort By:
Pageof 29
Journal of Virology|June 7, 2002
Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediatesHana Golding, Marina Zaitseva, Eve de Rosny, et al.
Plos One|May 27, 2015
Identification of Non-HIV Immunogens That Bind to Germline b12 Predecessors and Prime for Elicitation of Cross-clade Neutralizing HIV-1 AntibodiesZheng Yang, Jingjing Li, Qingsheng Liu, et al.
Cell Reports|December 16, 2021
Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody bindingDhiraj Mannar, James W Saville, Xing Zhu, et al.
IJU Case Reports|August 4, 2020
Bladder urothelial carcinoma producing insulin-like growth factor II: A case reportSatoshi Funada, Yuki Kita, Yoshiyuki Okada, et al.
Scientific Reports|August 20, 2016
Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus InfectionAnurodh Shankar Agrawal, Tianlei Ying, Xinrong Tao, et al.
Translational Oncology|November 12, 2021
Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cellsNayanendu Saha, Kai Xu, Zhongyu Zhu, et al.
Mabs|April 14, 2018
N-terminal α-amino group modification of antibodies using a site-selective click chemistry methodDe-Zhi Li, Bing-Nan Han, Rui Wei, et al.
International Journal of Biological Sciences|June 19, 2018
A dual-specific IGF-I/II human engineered antibody domain inhibits IGF signaling in breast cancer cellsZhizhen Chen, Jie Liu, Dafeng Chu, et al.
Briefings in Bioinformatics|September 16, 2024
AI-based IsAb2.0 for antibody designTianjian Liang, Ze-Yu Sun, Margaret G Hines, et al.
Small Methods|February 17, 2022
Design of a Novel Fab-Like Antibody Fragment with Enhanced Stability and Affinity for Clinical useChunyu Wang, Jiaxu Hong, Zhenlin Yang, et al.
Pageof 29